Holders over time
- ABVX
- TMO
| Quarter | ABVX | TMO |
|---|---|---|
| Q3 2020 | none listed holders, n.a. | 29 holders, $38.9bn |
| Q4 2020 | none listed holders, n.a. | 33 holders, $39.2bn |
| Q1 2021 | none listed holders, n.a. | 35 holders, $36.5bn |
| Q2 2021 | none listed holders, n.a. | 33 holders, $38.3bn |
| Q3 2021 | none listed holders, n.a. | 32 holders, $42.6bn |
| Q4 2021 | none listed holders, n.a. | 38 holders, $50.1bn |
| Q1 2022 | none listed holders, n.a. | 32 holders, $43.2bn |
| Q2 2022 | none listed holders, n.a. | 33 holders, $38.9bn |
| Q3 2022 | none listed holders, n.a. | 26 holders, $34.3bn |
| Q4 2022 | none listed holders, n.a. | 29 holders, $37.0bn |
| Q1 2023 | none listed holders, n.a. | 35 holders, $37.1bn |
| Q2 2023 | none listed holders, n.a. | 39 holders, $33.5bn |
| Q3 2023 | none listed holders, n.a. | 39 holders, $32.6bn |
| Q4 2023 | none listed holders, n.a. | 41 holders, $32.7bn |
| Q1 2024 | none listed holders, n.a. | 30 holders, $34.1bn |
| Q2 2024 | none listed holders, n.a. | 38 holders, $30.6bn |
| Q3 2024 | none listed holders, n.a. | 30 holders, $33.8bn |
| Q4 2024 | none listed holders, n.a. | 36 holders, $27.6bn |
| Q1 2025 | none listed holders, n.a. | 31 holders, $24.2bn |
| Q2 2025 | none listed holders, n.a. | 39 holders, $18.8bn |
| Q3 2025 | 6 holders, $483m | 32 holders, $21.9bn |
| Q4 2025 | 10 holders, $743m | 32 holders, $29.9bn |
| Q1 2026 | 8 holders, $257m | 34 holders, $24.4bn |
| Q2 2026 | 8 holders, $482m | 36 holders, $26.4bn |
Abivax SA
- Holders
- 10
- Reported value
- $743m
- Buyers
- 13
- Sellers
- 11
Breadth +2 among 92 comparable managers.
Thermo Fisher Scientific Inc
- Holders
- 32
- Reported value
- $29.9bn
- Buyers
- 27
- Sellers
- 20
Breadth +7 among 92 comparable managers.
Who holds both, Q4 2025
Both (6)
Brevan Howard Capital Management LP, Farallon Capital Management LLC, Holocene Advisors LP, Janus Henderson Group Ltd, Point72 Asset Management LP, Woodline Partners LP
Only ABVX (4)
Balyasny Asset Management LLC, ExodusPoint Capital Management LP, Hudson Bay Capital Management LP, Millennium Management LLC
Only TMO (26)
AllianceBernstein LP, Arrowstreet Capital LP, Artisan Partners LP, Baillie Gifford & Co, Capital Research Global Investors, Capital World Investors, Citadel Advisors LLC, Dodge & Cox, Fidelity (FMR LLC), GAMCO Investors Inc, Glenview Capital Management LLC, Harris Associates LP, Invesco Ltd, Jane Street Group LLC, Markel Group Inc, Marshall Wace LLP, MFS Investment Management, Neuberger Berman Group LLC, Polen Capital Management LLC, Rokos Capital Management LLP, Steadfast Capital Management LP, T. Rowe Price Associates Inc, Third Point LLC, Verition Fund Management LLC, Viking Global Investors LP, and 1 more
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.